Acanthamoeba Keratitis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Acanthamoeba and Artificial Intelligence
Conditions: Acanthamoeba Keratitis; Artificial Intelligence Sponsors: IRCCS Ospedale San Raffaele Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials

Parasitic Ulcer Treatment Trial
Conditions: Acanthamoeba Keratitis Interventions: Drug: Polyhexamethylene biguanide (PHMB); Drug: Topical corticosteroid; Other: Topical placebo Sponsors: Jeremy Keenan, MD, MPH; Johns Hopkins University; Oregon Health and Science University; University of Illinois at Chicago; University of Michigan; University of California, Los Angeles; University of Miami; University of Pennsylvania; Columbia University; University of Iowa; University of Florida; Aravind Eye Care System; Moorfields Eye Hospital NHS Foundation Trust; Federal University of S ão Paulo; National Eye Institute (NEI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials

Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Subjects Affected by Acanthamoeba Keratitis
Condition: Acanthamoeba Keratitis Interventions: Drug: PHMB 0.08%; Drug: Propamidine 0.1%; Drug: placebo; Drug: PHMB 0.02% Sponsor: SIFI SpA Recruiting - verified September 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2017 Category: Research Source Type: clinical trials